Paper36836675
Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy.
Popescu D and 6 others. Life (Basel), 2023. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy. Papers, record 36836675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36836675
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References215
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10769275 | Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. | Circulation | 2000 | https://conductscience.org/library/papers/10769275 | PubMed |
| 2 | 25609412 | Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. | Ann Rheum Dis | 2016 | https://conductscience.org/library/papers/25609412 | PubMed |
| 3 | 36198438 | Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study. | Ann Rheum Dis | 2023 | https://conductscience.org/library/papers/36198438 | PubMed |
| 4 | 26150124 | Rheumatoid arthritis: Debunking the obesity-mortality paradox in RA. | Nat Rev Rheumatol | 2015 | https://conductscience.org/library/papers/26150124 | PubMed |
| 5 | 31312844 | Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up. | Rheumatology (Oxford) | 2020 | https://conductscience.org/library/papers/31312844 | PubMed |
| 6 | 22425941 | Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. | Ann Rheum Dis | 2012 | https://conductscience.org/library/papers/22425941 | PubMed |
| 7 | 33858620 | Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction. | J Am Coll Cardiol | 2021 | https://conductscience.org/library/papers/33858620 | PubMed |
| 8 | 30496103 | Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. | Lancet | 2018 | https://conductscience.org/library/papers/30496103 | PubMed |
| 9 | 32483312 | Cardiovascular disease and subclinical atherosclerosis in rheumatoid arthritis. | Hypertens Res | 2020 | https://conductscience.org/library/papers/32483312 | PubMed |
| 10 | 30527425 | Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. | Best Pract Res Clin Rheumatol | 2018 | https://conductscience.org/library/papers/30527425 | PubMed |
| 11 | 31520804 | MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact. | Autoimmun Rev | 2019 | https://conductscience.org/library/papers/31520804 | PubMed |
| 12 | 28183353 | Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation. | Arthritis Res Ther | 2017 | https://conductscience.org/library/papers/28183353 | PubMed |
| 13 | 34458905 | 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. | Eur Heart J | 2021 | https://conductscience.org/library/papers/34458905 | PubMed |
| 14 | 29930142 | Atherosclerosis and inflammation: overview and updates. | Clin Sci (Lond) | 2018 | https://conductscience.org/library/papers/29930142 | PubMed |
| 15 | 28073800 | Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis. | Ann Rheum Dis | 2017 | https://conductscience.org/library/papers/28073800 | PubMed |
| 16 | 24368514 | Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. | Ann Rheum Dis | 2015 | https://conductscience.org/library/papers/24368514 | PubMed |
| 17 | 28706194 | Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis. | Sci Rep | 2017 | https://conductscience.org/library/papers/28706194 | PubMed |
| 18 | 25577237 | Role of homocysteine in the development of cardiovascular disease. | Nutr J | 2015 | https://conductscience.org/library/papers/25577237 | PubMed |
| 19 | 28604350 | The Adipokine Omentin in Late-stage Rheumatoid Arthritis and Endstage Osteoarthritis. | J Rheumatol | 2017 | https://conductscience.org/library/papers/28604350 | PubMed |
| 20 | 26839473 | The Effects of Rituximab on Lipids, Arterial Stiffness and Carotid Intima-Media Thickness in Rheumatoid Arthritis. | J Korean Med Sci | 2016 | https://conductscience.org/library/papers/26839473 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942429 | Accelerated Atherosclerosis. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42942429 | PubMed |
| 42866159 | Lipid and immune profiles in children with systemic juvenile idiopathic arthritis: a case-control study with paired longitudinal comparison of disease activity. | Transl Pediatr | 2026 | https://conductscience.org/library/papers/42866159 | PubMed |
| 42513568 | Temporal Acoustic-Window Failure in Female Patients with Rheumatoid Arthritis: An Eight-Year Longitudinal Follow-Up Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42513568 | PubMed |
| 42453660 | The dual role of metabolic reprogramming in macrophage polarization in rheumatoid arthritis and coronary heart disease and the intervention strategy of traditional Chinese medicine. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42453660 | PubMed |
| 42400613 | Computational intelligence using nailfold videocapillaroscopy for the prediction of carotid intima-media thickness in rheumatoid arthritis: a cohort-based study. | Rheumatol Int | 2026 | https://conductscience.org/library/papers/42400613 | PubMed |
| 41913849 | Cardiovascular Outcomes and Vascular Surrogate Markers in Rheumatoid Arthritis Patients Treated With Anti-Tumour Necrosis Factor (TNF) Therapy: A Systematic Review and Meta-Analysis. | Cureus | 2026 | https://conductscience.org/library/papers/41913849 | PubMed |
| 41637288 | Subclinical atherosclerosis in rheumatoid arthritis: a case cohort analysis from ELSA-Brasil. | Braz J Med Biol Res | 2026 | https://conductscience.org/library/papers/41637288 | PubMed |
| 41567906 | Prevalence and Patterns of Dyslipidemia Among Patients With Rheumatoid Arthritis: A Retrospective Cohort Study. | Cureus | 2025 | https://conductscience.org/library/papers/41567906 | PubMed |
| 41415106 | Silymarin attenuates cardiac injury and inflammation in adjuvant-induced rheumatoid arthritis rats through activation of the Nrf2/SLC7A11/GPX4 signaling pathway. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/41415106 | PubMed |
| 41301673 | Enhanced mTORC1 Signaling in Inflammatory Monocytes Links Systemic Inflammation to Cardiovascular Disease in Rheumatoid Arthritis. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301673 | PubMed |
| 40937212 | Novel Biomarkers and Advanced Imaging in Cardiovascular Risk Stratification for Rheumatic Diseases. | Cureus | 2025 | https://conductscience.org/library/papers/40937212 | PubMed |
| 40727925 | Soluble interleukin-33 receptor (sST-2): a novel marker for assessing cardiovascular risk in rheumatoid arthritis. | J Circ Biomark | 2025 | https://conductscience.org/library/papers/40727925 | PubMed |
| 40727466 | Atherosclerosis and Inflammation: Are the Rules of the Game Changing with Biological Therapies? | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40727466 | PubMed |
| 40718057 | Interplay of rheumatoid arthritis and cardiovascular disease: Insights and prospects. | SAGE Open Med | 2025 | https://conductscience.org/library/papers/40718057 | PubMed |
| 40699690 | The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699690 | PubMed |
| 40351696 | Assessment of Carotid Stiffness and Strain Parameters Using Speckle Tracking Strain Ultrasonography in Rheumatoid Arthritis Patients. | Rev Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40351696 | PubMed |
| 40305360 | Persea americana Peel: A Promising Source of Nutraceutical for the Mitigation of Cardiovascular Risk in Arthritic Rats Through the Gut-Joint Axis. | Biomolecules | 2025 | https://conductscience.org/library/papers/40305360 | PubMed |
| 39710047 | Percutaneous coronary intervention (PCI) in patients of rheumatoid arthritis(RA): A systematic review and meta-analysis. | Indian Heart J | 2025 | https://conductscience.org/library/papers/39710047 | PubMed |
| 39669696 | SCORE2 is superior to SCORE in predicting the presence of carotid plaques and intima-media thickness in rheumatoid arthritis patients: a cross-sectional study using carotid ultrasound. | Ther Adv Musculoskelet Dis | 2024 | https://conductscience.org/library/papers/39669696 | PubMed |
| 39144547 | Emerging Landscape of In Vitro Models for Assessing Rheumatoid Arthritis Management. | ACS Pharmacol Transl Sci | 2024 | https://conductscience.org/library/papers/39144547 | PubMed |
Genes46
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36836675
GET https://conductscience.org/api/papers/v1/36836675/references?page=2